单剂量psilocybin在患有癌症的抑郁患者中的长期益处
Manish Agrawal1,2, Kim Roddy1, Betsy Jenkins1,2
1Sunstone Therapies, Rockville, Maryland, USA.
Cancer
|June 16, 2025
概括
在癌症患者中,单剂量psilocybin与心理支持显著降低了抑郁和焦虑. 这些积极的结果持续了两年,提供了一种新的治疗方法.
科学领域:
- 在瘤学瘤学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症患者经常经历抑郁症,影响他们的生活质量和治疗结果.
- 在癌症患者中管理抑郁症具有重大临床挑战.
研究的目的:
- 报告一项2期试验的2年疗效结果,该试验研究了西与癌症患者严重抑郁障碍的心理支持相结合.
- 评估这种新型治疗干预措施的长期安全性,可行性和有效性.
主要方法:
- 进行了2期临床试验,涉及30名患有癌症和严重抑郁症的患者.
- 参与者在社区癌症护理环境中接受了单剂量 псилоцибин (25毫克) 以及心理支持.
- 疗效结果,包括抑郁和焦虑水平,在基线和2年随访期间进行了评估.
主要成果:
- 2年后,53.6%的患者 (15/28) 显示抑郁症显著降低 (蒙特哥马利阿斯伯格抑郁症评分表,平均水平). -15.0分,p<.001分) 的情况.
- 在50%的患者中观察到持续的抑郁减轻 (14/28).
- 显著减少焦虑 (汉密尔顿焦虑评分表,平均年均) -13.9点,p < .001) 在46.4% (13/28),持续下降在42.9% (12/28).
结论:
- 一次25毫克的 псилоцибин剂量,与心理治疗相结合,在癌症患者中显示出强大的抗抑郁作用.
- 这些发现表明psilocybin辅助疗法作为一个潜在的范式改变替代传统抗抑郁药对这一群体.
- 需要进一步的研究来证实这些有希望的结果,并探索更广泛的临床应用.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
10:02Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
2.1K
相关概念视频
Long-term Depression
31.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.5K
The Placebo Effect
6.4K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
